EMEA-000609-PIP01-09-M01
Key facts
| Active substance |
Recombinant human glutamic acid decarboxylase (rhGAD65)
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0400/2017
|
| PIP number |
EMEA-000609-PIP01-09-M01
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of Type I Diabetes Mellitus
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Diamyd Therapeutics AB
|
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|